Enovis Corporation (ENOV)

USD 43.28

(-5.17%)

Market Cap (In USD)

2.41 Billion

Revenue (In USD)

1.7 Billion

Net Income (In USD)

-33.26 Million

Avg. Volume

634.79 Thousand

Currency
USD
Country
Industrials
Open
-
Prev. Close
-
Day Range
-
Year Range
38.27-65.03
PE
-
EPS
-
Beta Value
1.997
ISIN
US1940145022
CUSIP
194014502
CIK
1420800
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Industrials
Industry
Industrial - Machinery
CEO
Mr. Matthew L. Trerotola
Employee Count
-
Website
https://www.enovis.com
Ipo Date
2008-05-08
Details
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.